E1	Condition:T1 Name:T2
E3	Condition:T3 Name:T4
E5	Condition:T5 Name:T6
E7	Condition:T7 Name:T8 Temporality:E23
E9	Condition:T9 Name:T10
E11	Condition:T11 Name:T12
E12	Age:T19 Eq-Comparison:E17
E13	Eq-Comparison:T27 Operator:T13 Value:T21 Temporal-Unit:T38
E14	Eq-Comparison:T28 Operator:T14 Value:T24
E15	Eq-Comparison:T29 Operator:T15 Value:T25
E16	Eq-Comparison:T30 Operator:T16 Value:T26
E17	Eq-Comparison:T31 Operator:T20 Value:T22 Value2:T23 Value3:T23 Temporal-Unit:T18
E2	Observation:T32 Name:T33 Polarity:T34
E4	Observation:T35 Name:T36 Eq-Comparison:E13
E6	Or:T37 Arg:E2 Arg2:E4
E8	Observation:T39 Name:T40
E10	Observation:T42 Name:T43 Eq-Comparison:E15
E18	Observation:T44 Name:T45 Eq-Comparison:E16
E19	Or:T46 Arg:E10 Arg2:E18
E20	Procedure:T47 Name:T48 Temporality:E21
E21	Eq-Comparison:T49 Value:T50 Temporal-Unit:T51 Temporal-Period:T17
E22	Negation:T52 Negates:E20
E23	Eq-Comparison:T53 Temporal-Period:T54
E24	Condition:T55 Name:T56
E25	Condition:T57 Name:T58
E26	Or:T59 Arg:E24 Arg2:E25
E27	Or:T60 Arg:E9 Arg2:E11
E28	Or:T61 Arg:E1 Arg2:E3
E29	Condition:T62 Name:T63 Severity:T64
E30	Condition:T65 Name:T66
E31	Drug:T67 Name:T68 Temporality:E32
E32	Eq-Comparison:T69 Temporal-Period:T70
E33	Encounter:T71
E34	Negation:T72 Negates:E33
E35	Assertion:T73 Asserted:E34
E36	Modifier:T74 Modifies:T48
E37	Or:T75 Arg:E36 Arg2:E38
E38	Modifier:T76 Modifies:T48
E39	Other:T77 Is-Other:E7
E40	Other:T78 Is-Other:E25
E41	Other:T79 Is-Other:E30
T1	Condition 580 546	Human immunodeficiency virus infection
T2	Condition-Name 580 546	Human immunodeficiency virus infection
T3	Condition 621 587	congenital immune deficiency diseases
T4	Condition-Name 621 587	congenital immune deficiency diseases
T5	Condition 667 630	autoimmune diseases
T6	Condition-Name 667 630	autoimmune diseases
T7	Condition 449 421	liver diseases
T8	Condition-Name 449 421	liver diseases
T9	Condition 520 488	Pregnancy
T10	Condition-Name 520 488	Pregnancy
T11	Condition 533 501	lactation
T12	Condition-Name 533 501	lactation
T13	Eq-Operator 92 88	>
T14	Eq-Operator 178 167	>
T15	Eq-Operator 246 232	<
T16	Eq-Operator 294 278	>
T18	Eq-Temporal-Unit 136 127	years
T19	Age 114 107	Age
T20	Eq-Operator 126 118	to
T21	Eq-Value 97 92	0.5
T22	Eq-Value 123 115	18
T23	Eq-Value 130 121	55
T24	Eq-Value 182 170	10
T25	Eq-Value 250 235	40
T26	Eq-Value 299 282	1.5
T27	Eq-Comparison 102 97	> 0.5 year
T28	Eq-Comparison 210 198	> 10 times upper limit of normal
T29	Eq-Comparison 252 236	< 40%
T30	Eq-Comparison 299 282	> 1.5
T31	Eq-Comparison 136 127	18 to 55 years
T32	Observation 65 61	hepatitis b surface antigen
T33	Observation-Name 65 61	hepatitis b surface antigen
T34	Polarity 37 33	Positive
T35	Observation 90 86	hepatitis b virus DNA
T36	Observation-Name 90 86	hepatitis b virus DNA
T37	Or 68 64	or
T38	Eq-Temporal-Unit 102 97	year
T39	Observation 176 165	Serum total bilirubin level
T40	Observation-Name 176 165	Serum total bilirubin level
T41	Eq-Unit 210 198	upper limit of normal
T42	Observation 244 230	Prothrombin time activity
T43	Observation-Name 244 230	Prothrombin time activity
T44	Observation 292 276	prothrombin time international ratio
T45	Observation-Name 292 276	prothrombin time international ratio
T46	Or 255 239	or
T47	Procedure 367 345	analogues treatment
T48	Procedure-Name 367 345	analogues treatment
T49	Eq-Comparison 389 367	past half year
T50	Eq-Value 384 362	half
T51	Eq-Temporal-Unit 389 367	year
T52	Negation 315 295	not
T53	Eq-Comparison 434 406	active
T54	Eq-Temporal-Period 434 406	active
T55	Condition 482 452	Hepatocellular carcinoma
T56	Condition-Name 482 452	Hepatocellular carcinoma
T57	Condition 502 472	malignancy
T58	Condition-Name 502 472	malignancy
T59	Or 485 455	or
T60	Or 523 491	or
T61	Or 583 549	or
T62	Condition 645 609	diabetes
T63	Condition-Name 645 609	diabetes
T64	Severity 636 600	Severe
T65	Condition 710 671	organ dysfunctions
T66	Condition-Name 710 671	organ dysfunctions
T67	Drug 739 698	glucocorticoid
T68	Drug-Name 739 698	glucocorticoid
T69	Eq-Comparison 724 683	Using
T70	Eq-Temporal-Period 724 683	Using
T71	Encounter 776 731	follow-up
T72	Negation 764 721	not
T73	Assertion 760 717	can
T17	Eq-Temporal-Period 379 357	past
T74	Modifier 334 314	nucleotide
T75	Or 336 315	/
T76	Modifier 347 325	nucleoside
T77	Other 427 399	Other
T78	Other 491 461	other
T79	Other 681 642	Other
A1	Eq-Operator-Value T13 GT
A2	Eq-Operator-Value T14 GT
A3	Eq-Operator-Value T15 LT
A4	Eq-Operator-Value T16 GT
A6	Eq-Temporal-Unit-Value T18 year
A7	Eq-Operator-Value T20 BETWEEN
A8	Observation-Type-Value T33 lab
A9	Polarity-Value T34 positive
A10	Observation-Type-Value T36 lab
A11	Eq-Temporal-Unit-Value T38 year
A12	Eq-Unit-Value T41 ref-range-normal
A13	Observation-Type-Value T40 lab
A14	Observation-Type-Value T43 lab
A15	Observation-Type-Value T45 lab
A16	Eq-Temporal-Unit-Value T51 year
A17	Eq-Temporal-Period-Value T54 present
A18	Severity-Value T64 severe
A19	Eq-Temporal-Period-Value T70 present
A20	Assertion-Type-Value E35 hypothetical
A5	Eq-Temporal-Period-Value T17 past